Literature DB >> 7900618

Altered diastolic [Ca2+]i handling in human ventricular myocytes from patients with terminal heart failure.

D J Beuckelmann1, M Näbauer, C Krüger, E Erdmann.   

Abstract

To investigate whether the slow diastolic decay of [Ca2+]i in myocardium of patients with heart failure is a result of alterations of the Ca2+ adenosine triphosphatase of the sarcoplasmic reticulum of the sarcolemma, [Ca2+]i transients were recorded in voltage-clamped ventricular cells isolated from hearts of patients with terminal heart failure or from undiseased donor hearts. To isolate the [Ca2+]i-reuptake function of the sarcoplasmic reticulum, myocytes were dialyzed via the patch pipette with Na(+)-free solution and incubated in Ca(2+)-free and Na(+)-free solution to inhibit Na+/Ca2+ exchange. After superfusion with Ca(2+)-containing, Na(+)-free medium, the sarcoplasmic reticulum was loaded with Ca2+ through repetitive voltage-clamp pulses to +10 mV. Under these conditions, [Ca2+]i decay was significantly slower in myocytes from patients with heart failure (538 +/- 66 msec) than in controls (305 +/- 16 msec; p < 0.05). After the addition of 10 mmol/L of caffeine, [Ca2+]i levels did not show appreciable decay between two voltage-clamp pulses in diseased and undiseased myocytes. We conclude that diastolic decay of [Ca2+]i in ventricular myocytes from patients with terminal heart failure is partially the result of a decreased rate of Ca2+ reuptake by the sarcoplasmic reticulum. Sarcolemmal Ca2+ adenosine triphosphatase does not contribute significantly to cytoplasmic [Ca2+]i removal during an individual heartbeat.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7900618     DOI: 10.1016/0002-8703(95)90316-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  23 in total

1.  Relationship between K+ channel down-regulation and [Ca2+]i in rat ventricular myocytes following myocardial infarction.

Authors:  R Kaprielian; A D Wickenden; Z Kassiri; T G Parker; P P Liu; P H Backx
Journal:  J Physiol       Date:  1999-05-15       Impact factor: 5.182

Review 2.  Regulation of cardiac excitation-contraction coupling by action potential repolarization: role of the transient outward potassium current (I(to)).

Authors:  Rajan Sah; Rafael J Ramirez; Gavin Y Oudit; Dominica Gidrewicz; Maria G Trivieri; Carsten Zobel; Peter H Backx
Journal:  J Physiol       Date:  2003-01-01       Impact factor: 5.182

3.  A computational model of the human left-ventricular epicardial myocyte.

Authors:  Vivek Iyer; Reza Mazhari; Raimond L Winslow
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

4.  Pathophysiology of heart failure.

Authors:  E Erdmann
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

5.  Calcium handling proteins: structure, function, and modulation by exercise.

Authors:  Jamille Locatelli; Leonardo V M de Assis; Mauro C Isoldi
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

Review 6.  Hemodynamic assessment of diastolic function for experimental models.

Authors:  Leslie M Ogilvie; Brittany A Edgett; Jason S Huber; Mathew J Platt; Hermann J Eberl; Sohrab Lutchmedial; Keith R Brunt; Jeremy A Simpson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-03-27       Impact factor: 4.733

7.  [Heart rate and rate control : Prognostic value in cardiovascular diseases].

Authors:  F Custodis; J-C Reil; U Laufs; M Böhm
Journal:  Internist (Berl)       Date:  2012-01       Impact factor: 0.743

Review 8.  Remodeling of calcium handling in human heart failure.

Authors:  Qing Lou; Ajit Janardhan; Igor R Efimov
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 9.  Treatment of heart failure in patients with diabetes mellitus.

Authors:  Steven J Lavine; Steven D Gellman
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 10.  Electrophysiological remodeling in heart failure.

Authors:  Yanggan Wang; Joseph A Hill
Journal:  J Mol Cell Cardiol       Date:  2010-01-20       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.